Submitted by Anonymous (not verified) on 9 December 2025 - 14:25
Human medicines European public assessment report (EPAR): Gohibic, vilobelimab, Date of authorisation: 13/01/2025, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Gohibic, vilobelimab, Date of authorisation: 13/01/2025, Revision: 2, Status: Authorised